Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 111901-111950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT02977715
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
PHASE3Active, not recruiting
1,600 participants
Started: Feb 23, 2017 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT02914535
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
PHASE3Active, not recruiting
1,173 participants
Started: Feb 23, 2017 · Completed: Sep 30, 2026
1 condition2 sponsors323 locations
NCT02999477
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
PHASE1Active, not recruiting
32 participants
Started: Feb 23, 2017 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT02912312
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer
PHASE2Active, not recruiting
805 participants
Started: Feb 23, 2017 · Completed: Feb 28, 2031
9 conditions2 sponsors12 locations
NCT03825861
Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer
PHASE2Recruiting
27 participants
Started: Feb 23, 2017 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT03205995
Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome
PHASE3Recruiting
80 participants
Started: Feb 23, 2017 · Completed: Feb 29, 2020
2 conditions1 sponsor2 locations
NCT02834637
A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
PHASE3Active, not recruiting
930 participants
Started: Feb 23, 2017 · Completed: Mar 31, 2027
1 condition8 sponsors1 location
NCT02926911
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS
NAActive, not recruiting
997 participants
Started: Feb 22, 2017 · Completed: Jul 31, 2028
2 conditions9 sponsors141 locations
NCT02988960
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
PHASE1Active, not recruiting
163 participants
Started: Feb 22, 2017 · Completed: Mar 31, 2026
1 condition1 sponsor22 locations
NCT02757274
Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence
N/AActive, not recruiting
1,054 participants
Started: Feb 22, 2017 · Completed: Jul 31, 2027
1 condition2 sponsors28 locations
NCT03920774
The Natural History of Familial Dysautonomia
N/ARecruiting
400 participants
Started: Feb 22, 2017 · Completed: Dec 31, 2028
3 conditions1 sponsor2 locations
NCT03083288
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
PHASE1Active, not recruiting
30 participants
Started: Feb 22, 2017 · Completed: Feb 22, 2026
1 condition1 sponsor1 location
NCT02992522
Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1Active, not recruiting
22 participants
Started: Feb 21, 2017 · Completed: Aug 15, 2026
13 conditions3 sponsors2 locations
NCT03303586
Effects of Compression Stockings in Asthma Symptoms at Night
NARecruiting
40 participants
Started: Feb 21, 2017 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT03283852
Identifying New Genetic Causes to Development Disorders
N/ARecruiting
1,100 participants
Started: Feb 21, 2017 · Completed: Feb 21, 2027
3 conditions1 sponsor1 location
NCT03075696
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
PHASE1/PHASE2Recruiting
920 participants
Started: Feb 21, 2017 · Completed: Dec 31, 2029
1 condition1 sponsor38 locations
NCT03184038
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
NARecruiting
90 participants
Started: Feb 21, 2017 · Completed: Sep 30, 2026
2 conditions1 sponsor2 locations
NCT03191682
A First-in-Human Study of PRL3-ZUMAB
PHASE1Active, not recruiting
38 participants
Started: Feb 20, 2017 · Completed: Feb 20, 2027
1 condition2 sponsors1 location
NCT03178630
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
N/ARecruiting
150 participants
Started: Feb 20, 2017 · Completed: Feb 28, 2031
3 conditions1 sponsor1 location
NCT03137095
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
N/ARecruiting
150 participants
Started: Feb 20, 2017 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT04063631
Pulmonary Epithelium, Immunology and Development of Asthma: Breathing Together
N/ARecruiting
1,300 participants
Started: Feb 20, 2017 · Completed: Sep 18, 2024
2 conditions8 sponsors1 location
NCT03622359
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
NARecruiting
192 participants
Started: Feb 17, 2017 · Completed: Dec 31, 2028
3 conditions2 sponsors1 location
NCT03068442
The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition
PHASE2Active, not recruiting
45 participants
Started: Feb 17, 2017 · Completed: Sep 10, 2024
3 conditions2 sponsors2 locations
NCT02543866
Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms
PHASE1Recruiting
20 participants
Started: Feb 17, 2017 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06625216
Severe Asthma Network Italy
N/ARecruiting
5,000 participants
Started: Feb 17, 2017 · Completed: Feb 17, 2037
1 condition2 sponsors1 location
NCT03148054
Computed Tomography Vs. Endoscopy Study
N/ARecruiting
400 participants
Started: Feb 17, 2017 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT03634930
Josef Ressel Centre Perinatal Programming
N/ARecruiting
100 participants
Started: Feb 16, 2017 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT03146884
Swiss Autoimmune Hepatitis Cohort Study
N/ARecruiting
500 participants
Started: Feb 16, 2017 · Completed: Dec 31, 2030
2 conditions1 sponsor20 locations
NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
PHASE2Active, not recruiting
14 participants
Started: Feb 16, 2017 · Completed: Jul 31, 2025
9 conditions1 sponsor3 locations
NCT02845518
Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)
NARecruiting
180 participants
Started: Feb 16, 2017 · Completed: May 16, 2024
1 condition1 sponsor1 location
NCT03069469
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
PHASE1/PHASE2Active, not recruiting
120 participants
Started: Feb 16, 2017 · Completed: Aug 31, 2028
5 conditions1 sponsor24 locations
NCT03180216
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation
PHASE1Active, not recruiting
32 participants
Started: Feb 15, 2017 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT03066297
Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer
N/AActive, not recruiting
1,018 participants
Started: Feb 15, 2017 · Completed: Feb 15, 2027
1 condition1 sponsor1 location
NCT02875353
Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding
NARecruiting
180 participants
Started: Feb 15, 2017 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT02956291
Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors
NAActive, not recruiting
172 participants
Started: Feb 15, 2017 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03063463
Mechanisms of Weight Loss in Patients Diagnosed With Achalasia
N/AEnrolling by invitation
50 participants
Started: Feb 15, 2017 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03121248
Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years
NAActive, not recruiting
144 participants
Started: Feb 15, 2017 · Completed: Nov 15, 2026
1 condition1 sponsor1 location
NCT03146910
Swiss Primary Biliary Cholangitis Cohort Study
N/ARecruiting
500 participants
Started: Feb 15, 2017 · Completed: Dec 31, 2030
2 conditions1 sponsor13 locations
NCT03542409
Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas
NARecruiting
60 participants
Started: Feb 15, 2017 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT02923180
Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer
PHASE2Active, not recruiting
33 participants
Started: Feb 14, 2017 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT02843633
LEADERS FREE II: BioFreedom™ Pivotal Study
NAActive, not recruiting
1,203 participants
Started: Feb 14, 2017 · Completed: Mar 31, 2021
2 conditions1 sponsor66 locations
NCT02816021
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
PHASE2Active, not recruiting
24 participants
Started: Feb 14, 2017 · Completed: Feb 28, 2026
2 conditions3 sponsors1 location
NCT03015896
Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
36 participants
Started: Feb 14, 2017 · Completed: Dec 31, 2026
15 conditions2 sponsors2 locations
NCT03052985
Materiovigilance After Urinary Incontinence or Prolapse Surgery
N/AActive, not recruiting
19,000 participants
Started: Feb 14, 2017 · Completed: May 1, 2033
3 conditions2 sponsors31 locations
NCT03218137
Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions
PHASE4Recruiting
100 participants
Started: Feb 13, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04428528
Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy
N/ARecruiting
100 participants
Started: Feb 13, 2017 · Completed: Feb 13, 2029
1 condition1 sponsor1 location
NCT03124303
Interventions for Postoperative Delirium: Biomarker-3
N/ARecruiting
470 participants
Started: Feb 13, 2017 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT02492607
Management of Low-risk (Grade I and II) DCIS
NARecruiting
2,500 participants
Started: Feb 13, 2017 · Completed: Feb 1, 2034
1 condition3 sponsors60 locations
NCT03145688
Family Habit Physical Activity Study
NARecruiting
240 participants
Started: Feb 12, 2017 · Completed: Dec 31, 2025
1 condition6 sponsors1 location
NCT03024671
Epicutaneous Testing of Cosmetics for Skin Compatibility
NARecruiting
180 participants
Started: Feb 10, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location